ArticleScience translational medicine2016

Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells.

Bing Z Carter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.